The Dermatosis drugs in development market research report provides comprehensive information on the therapeutics under development for Dermatosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Dermatosis. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Dermatosis and features dormant and discontinued products.
GlobalData tracks five drugs in development for Dermatosis by five companies/universities/institutes. The top development phase for Dermatosis is preclinical with one drugs in that stage. The Dermatosis pipeline has five drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Dermatosis pipeline products market are: Aclaris Therapeutics, Peptide Logic and DermBiont.
The key targets in the Dermatosis pipeline products market include C-X-C Motif Chemokine 2, C-C Motif Chemokine 3, and Interleukin 8.
The key mechanisms of action in the Dermatosis pipeline product include Kappa Type Opioid Receptor Agonist with one drug in Unknown. The Dermatosis pipeline products include four routes of administration with the top ROA being Intravenous and four key molecule types in the Dermatosis pipeline products market including Small Molecule, and Cell Therapy.
Dermatosis overview
A dermatosis is any skin defect or lesion on the skin that doesn’t cause inflammation. Atopic dermatitis, contact dermatitis, and seborrheic dermatitis are some common types of dermatoses. Some common causes of dermatosis include autoimmune disorders, psoriasis, atopic dermatitis, acne, and dermatophytosis. Symptoms include itchy and dry skin, rashes, blistering, oozing, crusting, and flaking. Treatments for dermatosis depend on the cause. It can include topical steroids, moisturizers, antibiotics, antifungals, or chemotherapy.
For a complete picture of Dermatosis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
